Scherm­afbeelding 2024 08 20 om 12.07.55

ELRIG UK and The Protein Society collaborate to advance protein sciences in drug discovery

The European Laboratory Research & Innovation Group (ELRIG) UK and The Protein Society (TPS) have announced a partnership aimed at advancing protein sciences in drug discovery. This collaboration will culminate in a joint conference, ‘Protein Sciences in Drug Discovery’, scheduled for 18-19 November 2024 in Cambridge, UK.

AdobeStock 892534593

Sapio Sciences unveils partner programme to boost research and diagnostic capabilities

In a move set to advance the lab informatics landscape, Sapio Sciences has launched its Partner Programme. This initiative aims to foster a robust ecosystem of technology vendors, service providers, and resellers, equipping them with essential resources to deliver cutting-edge solutions for scientists.

Surfix Diagnostics 1

New collaboration aims to enhance colorectal cancer screening accuracy

A new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]

SciRhom

SciRhom raises €63 million to advance iRhom2-targeting therapies for autoimmune diseases

Munich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]

Emile Shaffu

Newcells Biotech bolsters commercial team with key appointment

Newcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.

AdobeStock 358683298

Cellular Origins acquires ACTIA Platform to enhance automated cell therapy production

Cellular Origins, a TTP company specialising in cell and gene therapy (CGT) manufacturing solutions, has announced the acquisition of the Autologous Cell Therapy Industrial Automation (ACTIA) Platform intellectual property. The acquisition is set to augment the company’s existing Constellation™ platform, which was launched in May 2023.

Autoimmune Encephalitis Mosaic 6

Together at the pulse of neurobiology

A unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]

Beckman Coulter Clar 1

Beckman Coulter Diagnostics is committed to innovation and growth in Ireland

In July 2024, Beckman Coulter Diagnostics announced a €10 million investment and 80 jobs for its site in mid-west Ireland. CLI caught up with Kevin O’Reilly, President of Beckman Coulter Diagnostics, to find out more about the company’s aims, its commitment to the site in Ireland, and how a world-class diagnostics development facility can be […]

Scherm­afbeelding 2024 08 19 om 19.57.35

INTEGRA Your reliable partner for productive pipettes

INTEGRA is a leading provider of high quality laboratory tools and consumables for liquid handling. We are committed to fulfilling the needs of laboratory professionals in research, diagnostics and quality control within the life sciences industry.

Biosynth Peptide Toolset

Biosynth’s custom peptide quotation tool now fully automatic

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, has unveiled the next step in its custom peptide revolution.